One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2020-136373
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 6 |
Affiliation: The University of Texas MD Anderson Cancer Center, City of Hope, University of California, Los Angeles, Northwell Health, University of Nebraska Medical Center, University of Rochester, Cornell University, University of California, San Diego, Oregon Health & Science University, Swedish Medical CenterVLS-101, a ROR1-Targeting Antibody-Drug Conjugate, Demonstrates a Predictable Safety Profile and Clinical Efficacy in Patients with Heavily Pretreated Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
